Eye On Quality And Price, Govt Plans Single Platform To Source Medicines

MUMBAI : The government plans to create a common platform to handle procurement of medicines for all Central government agencies, including the Central Government Health Scheme (CGHS), institutions and public sector undertakings. The objective is to reap the benefits of a bulk purchase through a common mechanism, where drugs will be of uniform quality and pricing, across the country.

Overall, Central and state governments’ drug procurement is estimated to be Rs 22,000 crore annually, or about 15% of the total pharma market.

At present, the same medication may be purchased by different government organisations and separate ministries — health and chemicals & fertilisers, at different prices. Significantly, the move could also prevent the practice of over-billing by certain pharma companies, and offer high-value critical products at a reduced price, resulting in huge savings for the government, sources told TOI.

A major part of the government procurement is used for schemes and institutions including Jan aushadhi, CGHS, AIIMS and Employees’ State Insurance Corporation. The mechanism being discussed is only for procurement by the Centre, as states have their independent system in place.

The matter has been discussed by both ministries — health & family welfare and Chemicals & Fertilisers with presentations made by entities including GeM (Government e-Market Place), sourcesadded. Among the possible entities which could be roped in include GeM and Indian Drugs and Pharmaceuticals Ltd. Further, for sourcing products like vitamins, basic antibiotics and paracetamol preference could be given to micro, small and medium enterprises, sources said.

  • Related Posts

    • Pharma
    • December 23, 2024
    • 73 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 106 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt